Skip to main content

Hudson Bay Capital Management LP

Position in LRMR — Larimar Therapeutics, Inc.

CIK 1393825 STAMFORD, CT

Position in LRMR

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$1,315,125
+$11,985 QoQ
Shares Held
292,250
-27.6% QoQ
Ownership
0.281%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2025
3 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LRMR Over Time

Shares Held

Position Value (USD)

Derivatives in LRMR

reported options exposure · as of Sep 30, 2025
CallValue
$1,609,186
CallShares
498,200
PutValue
$1,217,710
PutShares
377,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Hudson Bay Capital Management LP holds $537,145,014 across 151 Biotechnology names. LRMR ranks #56 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in LRMR

Export CSV
6 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,315,125 292,250
2025-09-30 $1,609,186 498,200
2025-09-30 $1,303,140 403,449
2025-09-30 $1,217,710 377,000
2025-06-30 $661,119 228,761
2025-06-30 $1,439,220 498,000